May 28, 2020
AXONIS Therapeutics, Inc. Announces Seed Financing for Preclinical Development of Neuromodulating KCC2 Therapy
Novel Technology Reactivates the Neural Tissue after Spinal Cord Injury CAMBRIDGE, Mass,–(BUSINESS WIRE)–AXONIS Therapeutics, Inc., an emerging biotechnology company advancing…